Liliana Gomez Flores Ramos

Dr. Liliana Gomez Flores Ramos

Population Health Research Center, National Institute of Public Health
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2020 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
SMSergio Meneses-Navarro
Sergio Meneses-Navarro
MFMaría Graciela Freyermuth-Enciso
María Graciela Freyermuth-Enciso
BPBlanca Estela Pelcastre-Villafuerte
Blanca Estela Pelcastre-Villafuerte
RCRoberto Campos-Navarro
Roberto Campos-Navarro
DMDavid Mariano Meléndez-Navarro
David Mariano Meléndez-Navarro
Liliana Gomez Flores RamosLiliana Gomez Flores Ramos
Liliana Gomez Flores Ramos
The coronavirus disease 2019 (COVID-2019) pandemic struck Latin America in late February and is now beginning to spread across the rural indigenous communities in the region, home to 42 million people. Eighty percent of this highly marginalized population is concentrated in Bolivia, Guatemala, Mexico and Peru. Health care services for these ethnic groups face distinct challenges in view of their high levels of marginalization and cultural differences from the majority. Drawing on 30 years of work on the responses of health systems in the indigenous communities of Latin America, our group of researchers believes that countries in the region must be prepared to combat the epidemic in indigenous settings marked by deprivation and social disparity. We discuss four main challenges that need to be addressed by governments to guarantee the health and lives of those at the bottom of the social structure: the indigenous peoples in the region. More than an analysis, our work provides a practical guide for designing and implementing a response to COVID-19 in indigenous communities.

1 January 2013 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
RRRamiro Ramírez-Patiño
Ramiro Ramírez-Patiño
LVLuis Eduardo Figuera Villanueva
Luis Eduardo Figuera Villanueva
APAna María Puebla Pérez
Ana María Puebla Pérez
JDJorge Iván Delgado-Saucedo
Jorge Iván Delgado-Saucedo
MLMaría Magdalena Legazpí-Macias
María Magdalena Legazpí-Macias
Martha GallegosMartha Gallegos
Martha Gallegos
Ramírez-Patiño R, et al. J Korean Med Sci. 2013 Nov;28(11):1587-1594. https://doi.org/10.3346/jkms.2013.28.11.1587

1 October 2017 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
Liliana Gomez Flores RamosLiliana Gomez Flores Ramos
Liliana Gomez Flores Ramos
RARosa Alvarez
Rosa Alvarez
CVCynthia Villarreal-Garza
Cynthia Villarreal-Garza
TWTalia Wegman
Talia Wegman
AMAlejandro Mohar
Alejandro Mohar

16 February 2018 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
APAlexander Perdomo-Pantoja
Alexander Perdomo-Pantoja
SMSonia Iliana Mejía-Pérez
Sonia Iliana Mejía-Pérez
Liliana Gomez Flores RamosLiliana Gomez Flores Ramos
Liliana Gomez Flores Ramos
MLMontserrat Lara-Velazquez
Montserrat Lara-Velazquez
COCordelia Orillac
Cordelia Orillac
TWTalia Wegman
Talia Wegman

1 January 2013 in Genetics and Molecular Research
Verified
Journal Article
Closed access
Liliana Gomez Flores RamosLiliana Gomez Flores Ramos
Liliana Gomez Flores Ramos
ADA. Escoto-De Dios
A. Escoto-De Dios
APAna María Puebla Pérez
Ana María Puebla Pérez
LFL.E. Figuera-Villanueva
L.E. Figuera-Villanueva
ARA. Ramos-Silva
A. Ramos-Silva
Martha GallegosMartha Gallegos
Martha Gallegos
The tumor necrosis factor-alpha (TNF-α) gene plays an important role in cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, insulin resistance, and endothelial function. Polymorphisms of TNF-α have been associated with cancer. We examined the role of the -308G>A polymorphism in this gene by comparing the genotypes of 294 healthy Mexican women with those of 465 Mexican women with breast cancer. The observed genotype frequencies for controls and breast cancer patients were 1 and 14% for AA, 13 and 21% for GA, and 86 and 65% for GG, respectively. We found that the odds ratio (OR) for AA genotype was 2.4, with a 95% confidence interval (95%CI) of 5.9-101.1 (P = 0.0001). The association was also evident when comparing the distribution of the AA-GA genotype in patients in the following categories: 1) premenopause and obesity I (OR = 3.5, 95%CI = 1.3-9.3, P = 0.008), 2) Her-2 neu and tumor stage I-II (OR = 2.5, 95%CI = 1.31-4.8, P = 0.004), 3) premenopause and tumor stage III-IV (OR = 1.7, 95%CI = 1.0-2.9, P = 0.034), 4) chemotherapy non-response and abnormal hematocrit (OR = 2.4, 95%CI = 1.2-4.8, P = 0.015), 5) body mass index and Her-2 neu and III-IV tumor stage (OR = 2.8, 95%CI = 1.2- 6.6, P = 0.016), and 6) nodule metastasis and K-I67 (OR = 4.0, 95%CI = 1.01-15.7, P = 0.038). We concluded that the genotypes AA-GA of the -308G>A polymorphism in TNF-α significantly contribute to breast cancer susceptibility in the analyzed sample from the Mexican population.

25 July 2017
Verified
Journal Article
Closed access
Liliana Gomez Flores RamosLiliana Gomez Flores Ramos
Liliana Gomez Flores Ramos
ACAndrea Castro-Sanchez
Andrea Castro-Sanchez
OPOmar Peña-Curiel
Omar Peña-Curiel
AMAlejandro Mohar
Alejandro Mohar